Effect of pH and sodium chloride on the strength and selectivity of the interaction of τ-cyclodextrin with some antisense nucleosides

International Journal of Pharmaceutics

Volumn 254, Issue 2, 2003, Pages 189-196

  Cserháti, Tibor ^a   Forgács, Esther ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Antisense nucleosides; Gamma cyclodextrin; Molecular interaction

Indexed keywords

DEOXYADENOSINE DERIVATIVE; DEOXYURIDINE DERIVATIVE; GAMMA CYCLODEXTRIN; NUCLEOSIDE; SODIUM CHLORIDE;

ARTICLE; MOLECULAR INTERACTION; PH; PRIORITY JOURNAL;

EID: 0037467164     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00031-0     Document Type: Article

References (25)

1. Allam M., Renzi P.M. Inhibition of GM-CSF-3/IL-5 signaling by antisense oligodeoxynucleotides targeting the common beta chain of their receptors. Antisense Nucleic Acid Drug Dev. 11:2001;289-300.
2. Cserháti T., Forgács E. Effect of gamma-cyclodextrin, methanol and pH on the parameters of reversed-phase thin-layer chromatography of some antisense nucleosides. J. Incl. Phenom. Macrocycl. Chem. 38:2000;453-465.
3. Cserháti T., Forgács E. Quantitative relationship between the chemical structure of antisense nucleosides and their capacity to interact with cyclomalto-octaose. Eur. J. Pharm. Biopharm. 51:2001;39-44.
4. Cserháti T., Forgács E., Sági G. Interaction of antiviral nucleosides with gamma cyclodextrin studied by charge transfer thin-layer chromatography. J. Liq. Chromatogr. Relat. Technol. 22:1999;125-135.
5. Ferrari M.E., Rusalov D., Enas J., Wheeler C.J. Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes. Nucleic Acid Res. 30:2002;1808-1816.
6. Formoso C. Interaction of β-cyclodextrin with nucleic acid monomer units. Biochem. Biophys. Res. Commun. 50:1973;999-1005.
7. Formoso C. Interaction of β-cyclodextrin with dinucleoside phosphates. Biopolymers. 13:1974;909-917.
8. Garcia-Chaumont C., Seksek O., Jolles B., Bolard J. A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 10:2000;177-184.
9. Ghosh C., Iversen P.L. Intracellular delivery strategies for antisense phosphorodiamidate. Antisense Nucleic Acid Drug Dev. 10:2000;263-274.
10. Hamoir T., Cuaste Sanchez F., Bourguignon B., Massart D.L. Spectral mapping analysis: a method for the characterization of stationary phases. J. Chromatogr. Sci. 32:1994;488-498.
11. Hoffman J.L., Bock R.M. Interaction of cyclodextrins with nucleic acids. A study of secondary structure in three transfer ribonucleic acids. Biochemistry. 9:1970;3542-3550.
12. Lewi P.J. Spectral mapping, a technique for classifying biological activity profiles of chemical compounds. Arzneim. Forsch. 26:1976;1295-1300.
13. Lewi P.J. Spectral map analysis. Factorial analysis of contrast, especially from log ratios. Chemom. Intell. Lab. Syst. 5:1989;105-116.
14. Mager, H., 1982. Moderne Regressionsanalyse, Salle, Sauerlander, Frankfurt am Main, pp. 135-167.
15. Nieto M.I., Caamano O., Fernandez F., Gomez M., Balzarini J., De Clerq E. Synthesis, antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues. Nucleosides Nucleotides Nucleic Acids. 21:2002;243-255.
16. Oros G., Cserháti T., Forgács E. Use of spectral mapping and stepwise regression analysis for the assessment of the relationship between chemical structure and biological activity of surfactants. Chemom. Intell. Lab. Syst. 39:1997;95-101.
17. Oros G., Cserháti T., Forgács E. Inhibitory effect of nonionic surfactants on sunflower downy mildew. A quantitative structure-activity relationship study. Chemom. Intell. Lab. Syst. 47:1999;149-156.
18. Pichon C., Feulon I., Midoux P., Mayer R., Monsigny M., Roche A.-C. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide. Antisense Nucleic Acid Drug Dev. 7:1997;335-343.
19. Sammon J.W. Jr. A nonlinear mapping for data structure analysis. IEEE Trans. Comput. C18:1969;401-407.
20. Szoka F.C., Xu Y., Zelphati O. How are nucleic acid released in cells from cationic lipid-nucleic acid complexes? J. Liposome Res. 6:1996;567-587.
21. Takle G.B., Thierry S.M., Flynn S.M., Peng B., White W., de Vonish R.A., Galbraith A.R., Goldberg A.R., George S.T. Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme). Antisense Nucleic Acid Drug Dev. 7:1997;177-185.
22. Taylor A.H., Pringle J.H., Bell S.C., Al-Azzawi F. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides. Antisense Nucleic Acid Drug Dev. 11:2001;219-231.
23. Vandeginste, B.G.M., Massart, D.L., Buydens, L.M.C., De Jong, S., Lewi, P.J., Smeyers-Verbeke, J., 1998. Handbook of Chemometrics and Qualimetrics. Part B. Data Handling in Science and Technology, vol. 20B. Elsevier, Amsterdam.
24. Zhao Q.Y., Temsamani J., Agrawal S. Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Nucleic Acid Drug Dev. 7:1997;185-192.
25. Zobel H.P., Kreuter J., Werner J., Noe C.R., Kumel G., Zimmer A. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:1997;483-493.